Details of the Drug Excipient
General Information of Drug Inactive Ingredient (DIG) (ID: E00047)
| DIG Name |
Taurine
|
||||
|---|---|---|---|---|---|
| Synonyms |
taurine; 2-aminoethanesulfonic acid; 107-35-7; L-Taurine; Ethanesulfonic acid, 2-amino-; tauphon; 2-Aminoethylsulfonic acid; O-Due; 2-Sulfoethylamine; taufon; Aminoethanesulfonic acid; aminoethylsulfonic acid; 2-aminoethane-1-sulfonic acid; beta-Aminoethylsulfonic acid; Taurinum [Latin]; Taurina [Spanish]; FEMA No. 3813; Taurine [INN]; CCRIS 4721; UNII-1EQV5MLY3D; NCI-C60606; AI3-18307; 2-amino-ethanesulfonic acid; NSC32428; MFCD00008197; 1EQV5MLY3D; 2-aminoethane sulfonic acid; .beta.-Aminoethylsulfonic acid; 1-Aminoethane-2-sulfonic acid; CHEBI:15891; NSC-32428; Taurine, 99%; NCGC00015997-06; DSSTox_CID_1304; DSSTox_RID_76069; DSSTox_GSID_21304; Taurine Hydrochloride; Taurina; Taurinum; C2H7NO3S; CAS-107-35-7; SMR000326743; SR-01000076144; EINECS 203-483-8; NSC 32428; Taurine [USP:INN:BAN]; Taurineold; Taukard; HSDB 8167; Aminoethylsulfonate; Taurine,(S); Taurine (TN); b-Aminoethylsulfonate; Taurine (8CI); 2-Aminoethylsulfonate; 70155-54-3; 2-aminoethyl sulfonate; beta-Aminoethylsulfonate; PubChem18250; Taurine-[13C2]; Tocris-0209; 2aminoethanesulfonic acid; Taurine, >=99%; b-Aminoethylsulfonic acid; Lopac-T-0625; WLN: Z2SWQ; 1-Aminoethane-2-sulfonate; ACMC-2098vs; bmse000120; bmse000805; bmse000863; EC 203-483-8; 2-aminoethanesulfonic acid.; Lopac0_001134; SCHEMBL23068; Taurine, >=98%, FG; MLS000859681; MLS001332383; MLS001332384; ARONIS27193; Taurine (JP17/USP/INN); Aminoethylsulfonic acid (JAN); CHEMBL239243; GTPL2379; DTXSID3021304; Taurine-1,1,2,2-[d4]; Taurine, >=99.0% (T); HMS2093L13; HMS2233D19; HMS3263D09; HMS3370J18; Pharmakon1600-01505463; HY-B0351; RKL10149; ZINC3809490; Tox21_110277; Tox21_202520; Tox21_501134; ANW-15782; BDBM50357220; NSC759150; s2008; STL197941; AKOS005208848; Tox21_110277_1; CCG-205208; DB01956; Ethanesulfonic acid, 2-amino- (9CI); LP01134; MCULE-6041857208; NE10562; NSC-759150; SDCCGSBI-0051101.P003; Taurine, BioUltra, >=99.5% (T); Taurine, SAJ first grade, >=98.5%; NCGC00015997-01; NCGC00015997-02; NCGC00015997-03; NCGC00015997-04; NCGC00015997-05; NCGC00015997-07; NCGC00015997-08; NCGC00015997-10; NCGC00015997-20; NCGC00024497-01; NCGC00024497-02; NCGC00024497-03; NCGC00024497-04; NCGC00024497-05; NCGC00260069-01; NCGC00261819-01; AS-13587; I815; NCI60_002814; SBI-0051101.P002; Taurine, Vetec(TM) reagent grade, >=99%; A0295; AM20080018; B1846; EU-0101134; FT-0611241; T-130; C00245; D00047; T 0625; AB00443712-07; AB00443712_09; AB00443712_10; Q207051; J-508042; SR-01000076144-1; SR-01000076144-3; SR-01000076144-5; Taurine, certified reference material, TraceCERT(R); F2191-0280; Z1317839154; Taurine, cell culture tested, meets USP testing specifications; Taurine, United States Pharmacopeia (USP) Reference Standard; Taurine, Pharmaceutical Secondary Standard; Certified Reference Material; Taurine, PharmaGrade, Ajinomoto, Manufactured under appropriate GMP controls for pharma or biopharmaceutical production, suitable for cell culture
|
||||
| DIG Function |
Buffering agent
|
||||
| Formula |
C2H7NO3S
|
||||
| Canonical SMILES |
C(CS(=O)(=O)O)N
|
||||
| InChI |
1S/C2H7NO3S/c3-1-2-7(4,5)6/h1-3H2,(H,4,5,6)
|
||||
| InChIKey |
XOAAWQZATWQOTB-UHFFFAOYSA-N
|
||||
| Physicochemical Properties | Molecular Weight | 125.15 | Topological Polar Surface Area | 88.8 | |
| XlogP | -4.1 | Complexity | 120 | ||
| Heavy Atom Count | 7 | Rotatable Bond Count | 2 | ||
| Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 4 | ||